The government-funded venture capital firm TMF Management Co (TMF管顧公司) yesterday said it is talking to several public and private investors to raise as much as NT$5 billion (US$172.89 million) by December, with the aim of putting Taiwan on the global biotech map.
The fund, called Taiwan Medtech Fund (TMF), got an injection of NT$1 billion from the Executive Yuan’s National Development Fund in June.
State-run firms including CPC Corp, Taiwan (台灣中油), China Steel Corp (中鋼), Taiwan Sugar Corp (台糖) and Taiwan Salt Co (台鹽) are involved in the talks and their combined investments will be not exceed NT$1 billion, TMF Management chairman Jang Yue-teh (張有德) said.
“We are also looking to private firms for capital,” he told reporters, adding that investor targets include entrepreneurs who have passion for medical health, especially those who have experience in the field or who had family members that have suffered from serious illnesses.
Hon Hai Group (鴻海集團) chairman Terry Gou’s (郭台銘) younger brother died of bone marrow cancer, while Quanta Computer Inc (廣達) chairman Barry Lam (林百里) has battled lung cancer.
When asked if firms such as Hon Hai were on the target list, Jang declined to comment, but said there would be more announcements soon.
“Taiwan has been talking about developing its biotech sector for more than 20 years,” he said. “But progress is going nowhere given a lack of talent, capital and an understanding of its importance.”
The venture capitalist plans to set up incubation centers that will generate, develop and -commercialize new ideas, and help market the end products in China, where the huge market could lead to big sales possibilities, said Stan Shih (施振榮), chairman of iD SoftCapital Inc (智融集團) and the founder of Acer Group (宏碁集團).
iD SoftCapital was invited by TMF Management to share its experiences and the former has not ruled out the possibility of investing in some projects.
The incubation centers would generate ideas mainly through research institutes and from academics, although they may come from anywhere in the world, as long as the ideas benefit Taiwan in certain ways, Jang said.
He said viable projects would either need to have their products produced here, or include -Taiwanese research and development teams, or Taiwan would have to have a say in the commercialization of the product, he said.
TMF is looking to invest in projects that research illnesses such as diabetes, sleeping disorders, cardiovascular disease and in fields including neurosciences and orthopedics, as well as remote and home-care medical services.
Jang is a partner in the US-based Vertical Group, a venture capital firm focused on medical technology and biotechnology.
He has more than 20 years of experience in various executive positions in the healthcare industry and currently serves on the boards of directors of Dynamic Implants, Forte Bio Inc and Inphenix Corp.
Prior to the Vertical Group, he was president and CEO of Embol-X, a private company engaged in the development of proprietary medical devices to prevent strokes during cardiac surgery.
Taiwan’s foreign exchange reserves fell below the US$600 billion mark at the end of last month, with the central bank reporting a total of US$596.89 billion — a decline of US$8.6 billion from February — ending a three-month streak of increases. The central bank attributed the drop to a combination of factors such as outflows by foreign institutional investors, currency fluctuations and its own market interventions. “The large-scale outflows disrupted the balance of supply and demand in the foreign exchange market, prompting the central bank to intervene repeatedly by selling US dollars to stabilize the local currency,” Department of Foreign
Intel Corp is joining Elon Musk’s long-shot effort to develop semiconductors for Tesla Inc, Space Exploration Technologies Corp and xAI, marking a surprising twist in the chipmaker’s comeback bid. Intel would help the Terafab project “refactor” the technology in a chip factory, the company said on Tuesday in a post on X, Musk’s social media platform. That is a stage in the development process that typically helps make chips more powerful or reliable. The chipmaker’s shares jumped 4.2 percent to US$52.91 in New York trading on Tuesday. The Terafab project is a grand plan by Musk to eventually manufacture his own chips for
Taiwan Power Co (Taipower, 台電) yesterday said it plans to resume operations at two coal-fired power generators for three months to boost security of electricity supply as liquefied natural gas (LNG) supply risks are running high due to the Middle East conflict. The two coal-fired power generators are at Mailiao Power Plant in Yunlin County’s Mailiao Township (麥寮). The plant, operated by Formosa Plastics Group (台塑集團), supplied electricity to Taipower’s power grid until the end of last year. Taipower’s decision came about one month after Minister of Economic Affairs Kung Ming-hsin (龔明鑫) on March 10 said that the nation had no imminent
Some robotaxi passengers were left stranded in the middle of fast-moving traffic in a major Chinese city after their driverless vehicles stopped running, according to police and media reports on Wednesday. A preliminary investigation indicates more than 100 robotaxis came to a halt because of a “system malfunction,” police in the city of Wuhan said in a statement, without elaborating. No injuries were reported. One passenger told Chinese media that their robotaxi stopped after turning a corner. An instruction on a screen read: “Driving system malfunction. Staff are expected to arrive in 5 minutes.” After no one showed up, the passenger pushed